Trials / Completed
CompletedNCT06482346
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers (SAD Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is planned to investigate the safety, tolerability, and pharmacokinetics when a single intravenous dose of MT-3534 or a placebo is given to healthy adult male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MT-3534 | Solution for infusion; Intravenous (IV) |
| BIOLOGICAL | Placebo | Solution for infusion; Intravenous (IV) |
Timeline
- Start date
- 2024-08-09
- Primary completion
- 2025-07-09
- Completion
- 2025-07-09
- First posted
- 2024-07-01
- Last updated
- 2025-08-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06482346. Inclusion in this directory is not an endorsement.